Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Interviews

Author defends controversial OECD South African hospital report

In March, we examined a report by the OECD on the affordability of private hospitals in South Africa, and gave space to experts on either side of the debate to discuss the findings. We’re now giving the final author of the report, Tomas Roubal, an economist at the World Health Organisation (WHO), an opportunity to enter the debate after he presented his findings at the Board of Healthcare Funders conference this summer.

Interview: Salvador Cardona, CEO, Milenia Labs

Milenia Labs links Mexican diagnostic centres with lab groups in the United States, Canada and Spain to provide specialized tests. We speak to CEO Salvador Cardona about expanding in Latin America and potentially moving into provision.

Interview: Teemu Suna, CEO, Finnish biomedical company Brainshake

Brainshake is a Finnish biomedical company that claims to revolutionise blood testing. It tests for over 200 biomarkers opening a far broader window into the health state of an individual than existing blood tests. And despite beginning commercial operations just three years ago, it already has global ambitions and claims to be highly profitable – enough to secure €5m of primarily non-equity funding. We interviewed its CEO Teemu Suna.

Interview: Juan Carlos Negrette, Director, Global Health at University of Utah – Health Sciences

Just how valuable are foreign ventures and affiliations for big US academic medical centres such as Mayo and Johns Hopkins? How much revenue are they making and how are these partnerships changing? We ask Juan Carlos who heads up these activities at the University of Utah, and was formerly Managing Director at Johns Hopkins Medicine International.

Interview: Juan Manuel Contreras, director at Mexican private equity house Ámbar Capital

Mexican private equity house Ámbar Capital is planning to expand its 50-bed hospital Hospitaria in Escobedo, Nuevo León, into a network targeting middle-income Mexicans across the country's tier II cities. We speak to director Juan Manuel Contreras about low-cost healthcare and rolling into care services.

Interview: Omer Karahan MD, Partner, ValueHealth Consulting

How is the Turkish private healthcare sector faring? Who better to ask than Omer Karahan, whose firm ValueHealth specialises in the sector? How is the private sector faring in Turkey these days? Have recent events affected the private sector? And where are we today with the big PPPs?

Interview: Mark Adams, CEO of Anglo Arabian Heathcare, on how changes in UAE will create winners – and losers

The healthcare system in the UAE is unusual. Around 85 to 90% of the workforce is from overseas, there’s a fragmented payor market and too many hospitals and clinics chasing too few patients. Something has to change, and as it does, there are going to be winners and losers. Mark Adams, founder and CEO of UAE-based integrated healthcare provider Anglo Arabian Heathcare, shared his views with Healthcare Nova.

Interview: Dr Shuchin Bajaj, co-founder of Cygnus Hospitals in India: How to succeed in semi-urban areas

Five years ago, a group of doctors working in Northern India looked at the major hospital chains around them and thought ‘we can do this better’. Six years on from setting up Cygnus Hospitals, a mixture of clever cost-cutting and sensible spending, selective recruitment, timely patient turnaround and low-priced procedures has seen the group open a chain of 11 “superspeciality” hospitals in Northern India, with over 1,000 beds and a 1,600-strong medical workforce. We spoke to Dr Suchin Bajaj, a founding director of the group, as he looks to encourage investment into his business as it continues to expand.

Interview: Fernando Echevarne Santamaria, managing director, Echevarne laboratories

Faced with falling prices and limited expansion opportunities, Spain’s largest independent lab group Echevarne laboratories is trying to find new ways to grow. We speak to Fernando Echevarne Santamaria, managing director of Echevarne Laboratories, on whether the group's strategy to vertically integrate is paying off.

Interview: Joseph Kutzin, coordinator health financing policy, World Health Organisation (WHO)

We've spoken to Joseph Kutzin who advises governments across the world on the design of their health systems. In this interview, Kutzin with great lucidity and patience explains complex issues of health policy with examples from his global experience. He also gives his view on developments in some of the more tempestuous markets: South Africa and India.

Find Us